食品伙伴網(wǎng)訊 2022年10月13日,據(jù)歐盟食品安全局(EFSA)消息,歐盟營(yíng)養(yǎng)、新型食品和食物過(guò)敏原(NDA)研究小組就β-羥基丁酸鹽(β-hydroxybutyrate salts)作為新型食品的安全性發(fā)表科學(xué)意見(jiàn)。
經(jīng)過(guò)評(píng)估,專家小組得出結(jié)論,β-羥基丁酸鹽作為新型食品的安全性尚未得到證實(shí)。部分原文報(bào)道如下:
Following a request from the European Commission, the EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) was asked to deliver an opinion on β-hydroxybutyrate (BHB) salts as a novel food (NF) pursuant to Regulation (EU) 2015/2283. The NF consists of sodium, magnesium and calcium BHB salts, and is proposed to be used by adults as a food ingredient in a number of food categories and as food supplement. The data provided by the applicant about the identity, the production process and the compositional data of the NF over the course of the risk assessment period were overall considered unsatisfactory. The Panel noted inconsistencies in the reporting of the test item used in the subchronic toxicity study and human studies provided by the applicant. Owing to these deficiencies, the Panel cannot establish a safe intake level of the NF. The Panel concludes that the safety of the NF has not been established.
本文由食品伙伴網(wǎng)食品資訊中心編輯,供網(wǎng)友參考,有任何疑問(wèn),請(qǐng)聯(lián)系news@foodmate.net。